Predicting progression from cognitive impairment to alzheimer’s disease with the disease state index

Current Alzheimer Research

Volumn 12, Issue 1, 2015, Pages 69-79

  Hall, Anette ^a   Mattila, Jussi ^b   Koikkalainen, Juha ^b   Lötjonen, Jyrki ^b   Wolz, Robin ^c   Scheltens, Philip ^d   Frisoni, Giovanni ^e   Tsolaki, Magdalini ^f   Nobili, Flavio ^g   Freund Levi, Yvonne ^h   Minthon, Lennart ⁱ   Frölich, Lutz ^j   Hampel, Harald ^k   Visser, Pieter Jelle ^d,l   Soininen, Hilkka ^a,m  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^c Image Analysis Ltd   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^f ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^g UNIVERSITY OF GENOA   (Italy)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ LUND UNIVERSITY   (Sweden)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k SORBONNE UNIVERSITÉ   (France)

^l MAASTRICHT UNIVERSITY   (Netherlands)

^m KUOPIO UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

Alzheimer s disease; Cerebrospinal fluid (CSF); Computer assisted diagnosis; Dementia; DESCRIPA; Magnetic resonance imaging (MRI); Mild cognitive impairment (MCI)

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; TAU PROTEIN; APOLIPOPROTEINS E; BIOLOGICAL MARKERS;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE STATE INDEX; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NON AMNESTIC MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SUPPORT VECTOR MACHINE; AGED, 80 AND OVER; AREA UNDER CURVE; CEREBROSPINAL FLUID; CLINICAL TRIAL; DISEASE PROGRESSION; EUROPE; GENETICS; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TESTS; PHYSIOPATHOLOGY; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; AREA UNDER CURVE; BIOLOGICAL MARKERS; DISEASE PROGRESSION; EUROPE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; SENSITIVITY AND SPECIFICITY;

EID: 84921850733     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205012666141218123829     Document Type: Article

References (44)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 377: 1019-31 (2011).
2. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild cognitive impairment. Lancet 367: 1262-70 (2006).
3. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3): 270-9 (2011).
4. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease:recommendations from the National Institute on Aging-Alzheimer's Associationworkgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3):270-9 (2011).
5. Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, et al. Harmonized diagnostic criteria for Alzheimer's disease:recommendations. J Intern Med 275(3): 204-13 (2014).
6. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing researchdiagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol 13(6): 614-29 (2014).
7. Cui Y, Liu B, Luo S, Zhen X, Fan M, Liu T, et al. Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One 6: e21896 (2011).
8. Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75: 230-38 (2010).
9. Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, et al. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging 31: 1375-85 (2010).
10. Spulber G, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, et al. An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment. J Intern Med 273(4): 396-409 (2013).
11. Wolz R, Julkunen V, Koikkalainen J, Niskanen E, Zhang DP, Rueckert D, et al. Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease. PLoS One 6: e25446 (2011).
12. Barnes DE, Cenzer IS, Yaffe K, Ritchie CS, Lee SJ. Alzheimer's Disease Neuroimaging Initiative. A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease. Alzheimers Dement pii: S1552-5260(13)02941-5 (2014).
13. Gaser C, Franke K, Klöppel S, KoutsoulerisN, Sauer H, et al. BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease. PLoS One 8(6): e67346 (2013).
14. Mattila J, Koikkalainen J, Virkki A, Simonsen A, van Gils M, Waldemar G, et al. A disease state fingerprint for evaluation of Alzheimer's disease. J Alzheimers Dis 27: 163-76 (2011).
15. Mattila J, Koikkalainen J, Virkki A, van Gils M, Lötjönen J. Alzheimer's Disease Neuroimaging Initiative. Design and application of a generic clinical decision support system for multiscale data. IEEE Trans Biomed Eng 59: 234-40 (2012a).
16. Simonsen AH, Mattila J, Hejl AM, Garde E, van Gils M, Thomsen C, et al. Application of the PredictAD decision support tool to a Danish cohort of patients with Alzheimer's disease and other dementias. Dement Geriatr Cogn Disord 37(3-4): 207-13 (2014).
17. Simonsen AH, Mattila J, Hejl AM, Frederiksen KS, Herukka SK, Hallikainen M, et al. Application of the Predict AD software tool to predict progression in patients with mild cognitive impairment. Dement Geriatr Cogn Disord 34(5-6): 344-50 (2012).
18. Liu Y, Mattila J, Ruiz MÁ, Paajanen T, Koikkalainen J, van Gils M, et al. Predicting AD conversion: comparison between prodromal AD guidelines and computer assisted Predict AD tool. PLoS One 8(2): e55246 (2013).
19. Mattila J, Soininen H, Koikkalainen J, Rueckert D, Wolz R, Waldemar G, et al. Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects. J Alzheimers Dis 32: 969-79 (2012b).
20. Muñoz-Ruiz M, Hartikainen P, Hall A, Mattila J, Koikkalainen J, Herukka SK, et al. Disease State Fingerprint in frontotemporal degeneration with reference to Alzheimer's disease and mild cognitive impairment. JAD 35: 727-39 (2013).
21. Visser PJ, Verhey FR, Boada M, Bullock R, De Deyn PP, Frisoni GB, et al. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology 30(4): 254-65 (2008).
22. Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund- Levi Y, et al. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol 8: 619-27 (2009).
23. Vos S, van Rossum IA, Verhey F, Knol DL, Soininen H, Wahlund LO, et al. Prediction of Alzheimer's disease in subjects with amnestic and non-amnestic MCI. Neurology 80: 1124-32 (2013).
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work-Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944 (1984).
25. Norberg J, Graff C, Almkvist O, Ewers M, Frisoni GB, Frölich L, et al. Regional Differences in Effects of APOE ε4 on Cognitive Impairment in Non-Demented Subjects. Dement Geriatr Cogn Disord 32:135-142 (2011).
26. Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, et al. Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology 52:1555-62 (1999).
27. Wolz R, Aljabar P, Hajnal JV, Rueckert D. Manifold learning for biomarker discovery in MR imaging. Machine Learning in Medical Imaging 116-23 (2010).
28. Koikkalainen J, Lötjönen J, Thurfjell L, Rueckert D, Waldemar G, Soininen H. Multi-template tensor-based morphometry: application to analysis of Alzheimer's disease. Neuroimage 56:1134-44 (2011).
29. Lötjönen J, Wolz R, Koikkalainen J, Julkunen V, Thurfjell L, Lundqvist R, et al. Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease. Neuroimage 56: 185-96 (2011).
30. Belkin M, Niyogi P. Laplacianeigenmaps for dimensionality reduction and data representation. Neural Computation 15:1373-96 (2003).
31. Wolz R, Aljabar P, Hajnal JV, Lötjönen J, Rueckert D; Alzheimer's Disease Neuroimaging Initiative. Nonlinear dimensionality reduction combining MR imaging with non-imaging information. Med Image Anal 16: 819-30 (2012).
32. Rueckert D, Sonoda LI, Hayes C, Hill DL, Leach MO, Hawkes DJ. Nonrigidregistration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging 18(8):712-21 (1999).
33. Lötjönen JM, Wolz R, Koikkalainen JR, Thurfjell L, Waldemar G, Soininen H, et al. Fast and robust multi-atlas segmentation of brain magnetic resonance images. Neuroimage 49: 2352-65 (2010).
34. Brun CC, Lepor N, Pennec X, Lee AG, Barysheva M, Madsen SK, et al. Mapping the regional influence of genetics on brain structure variability - a tensor-based morphometry study. NeuroImage 48: 37-49 (2009).
35. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, et al. Neuroimaging Clin N Am 15: 869-77 (2005).
36. Aguilar C, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, et al. Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment. Psychiatry Res 212(2): 89-98 (2013).
37. Chincarini A, Bosco P, Gemme G, Esposito M, Rei L, Squarcia S, et al. Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study. Alzheimers Dement 13: 1552-5260 (2013).
38. Falahati F, Westman E, Simmons A. Multivariate data analysis and machinelearning in Alzheimer's disease with a focus on structural magnetic resonance imaging. J Alzheimers Dis 41(3): 685-708 (2014).
39. Clerx L, van Rossum I, Burns L, Knol DL, Scheltens P, Verhey F, et al. Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment. Neurobiol Aging 34(8):2003-13 (2013).
40. Jack C, Knopman D, Jagust W, Petersen R, Weiner M, Aisen P, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12(2): 207-216 (2103).
41. Gomar JJ, Harvey PD, Bobes-Bascaran MT, Davies P, Goldberg TE. Development and cross-validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry 19(11): 915-22 (2011).
42. Muñoz-Ruiz M, Hartikainen P, Koikkalainen J, Wolz R, Julkunen V, Niskanen E, et al. Structural MRI in frontotemporal dementia: Comparisons between hippocampal volumetry, tensor-based morphometry and voxel-based morphometry. PLoS One 7: e52531 (2012).
43. Koikkalainen J, Pölönen H, Mattila J, van Gils M, Soininen H, Lötjönen J. Improved classification of Alzheimer's disease data via removal of nuisance variability. PLoS One 7: e31112 (2012).
44. Hall A, Muñoz-Ruiz M, Mattila J, Koikkalainen J, Tsolaki M, Mecocci P, et al. Generalizability of the Disease State Index Prediction Model for IdentifyingPatients Progressing from Mild Cognitive Impairment to Alzheimer's Disease. J Alzheimers Dis (2014).